Literature DB >> 31444298

Pore-modulating toxins exploit inherent slow inactivation to block K+ channels.

Izhar Karbat1, Hagit Altman-Gueta2, Shachar Fine1, Tibor Szanto3, Shelly Hamer-Rogotner4, Orly Dym4, Felix Frolow2, Dalia Gordon1, Gyorgy Panyi3, Michael Gurevitz2, Eitan Reuveny5.   

Abstract

Voltage-dependent potassium channels (Kvs) gate in response to changes in electrical membrane potential by coupling a voltage-sensing module with a K+-selective pore. Animal toxins targeting Kvs are classified as pore blockers, which physically plug the ion conduction pathway, or as gating modifiers, which disrupt voltage sensor movements. A third group of toxins blocks K+ conduction by an unknown mechanism via binding to the channel turrets. Here, we show that Conkunitzin-S1 (Cs1), a peptide toxin isolated from cone snail venom, binds at the turrets of Kv1.2 and targets a network of hydrogen bonds that govern water access to the peripheral cavities that surround the central pore. The resulting ectopic water flow triggers an asymmetric collapse of the pore by a process resembling that of inherent slow inactivation. Pore modulation by animal toxins exposes the peripheral cavity of K+ channels as a novel pharmacological target and provides a rational framework for drug design.

Entities:  

Keywords:  block; neurotoxin; pore modulation; potassium channels; structural water

Mesh:

Substances:

Year:  2019        PMID: 31444298      PMCID: PMC6744907          DOI: 10.1073/pnas.1908903116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution.

Authors:  Y Zhou; J H Morais-Cabral; A Kaufman; R MacKinnon
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

2.  BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.

Authors:  Mei Zhang; Yuliya V Korolkova; Jie Liu; Min Jiang; Eugene V Grishin; Gea-Ny Tseng
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

3.  Energetics of pore opening in a voltage-gated K(+) channel.

Authors:  Ofer Yifrach; Roderick MacKinnon
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

4.  The binding of kappa-Conotoxin PVIIA and fast C-type inactivation of Shaker K+ channels are mutually exclusive.

Authors:  E Dietlind Koch; Baldomero M Olivera; Heinrich Terlau; Franco Conti
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

5.  A novel conus peptide ligand for K+ channels.

Authors:  Michael Ferber; Annett Sporning; Gunnar Jeserich; Richard DeLaCruz; Maren Watkins; Baldomero M Olivera; Heinrich Terlau
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

Review 6.  Novel interactions between K+ channels and scorpion toxins.

Authors:  Ricardo C Rodríguez de la Vega; Enrique Merino; Baltazar Becerril; Lourival D Possani
Journal:  Trends Pharmacol Sci       Date:  2003-05       Impact factor: 14.819

7.  Turret and pore block of K+ channels: what is the difference?

Authors:  Chen-Qi Xu; Shun-Yi Zhu; Cheng-Wu Chi; Jan Tytgat
Journal:  Trends Pharmacol Sci       Date:  2003-09       Impact factor: 14.819

8.  Identification of a novel pharmacophore for peptide toxins interacting with K+ channels.

Authors:  Laurent Verdier; Ahmed Al-Sabi; Jean E F Rivier; Baldomero M Olivera; Heinrich Terlau; Teresa Carlomagno
Journal:  J Biol Chem       Date:  2005-03-30       Impact factor: 5.157

9.  Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel.

Authors:  C S Park; C Miller
Journal:  Neuron       Date:  1992-08       Impact factor: 17.173

10.  Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3.

Authors:  Mark D Lanigan; Katalin Kalman; Yann Lefievre; Michael W Pennington; K George Chandy; Raymond S Norton
Journal:  Biochemistry       Date:  2002-10-08       Impact factor: 3.162

View more
  6 in total

1.  Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.

Authors:  Muhammad Umair Naseem; Edson Carcamo-Noriega; José Beltrán-Vidal; Jesus Borrego; Tibor G Szanto; Fernando Z Zamudio; Gustavo Delgado-Prudencio; Lourival D Possani; Gyorgy Panyi
Journal:  J Gen Physiol       Date:  2022-06-14       Impact factor: 4.000

Review 2.  Venom Peptide Toxins Targeting the Outer Pore Region of Transient Receptor Potential Vanilloid 1 in Pain: Implications for Analgesic Drug Development.

Authors:  Sung-Min Hwang; Youn-Yi Jo; Cinder Faith Cohen; Yong-Ho Kim; Temugin Berta; Chul-Kyu Park
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

3.  Modern venomics-Current insights, novel methods, and future perspectives in biological and applied animal venom research.

Authors:  Bjoern M von Reumont; Gregor Anderluh; Agostinho Antunes; Naira Ayvazyan; Dimitris Beis; Figen Caliskan; Ana Crnković; Maik Damm; Sebastien Dutertre; Lars Ellgaard; Goran Gajski; Hannah German; Beata Halassy; Benjamin-Florian Hempel; Tim Hucho; Nasit Igci; Maria P Ikonomopoulou; Izhar Karbat; Maria I Klapa; Ivan Koludarov; Jeroen Kool; Tim Lüddecke; Riadh Ben Mansour; Maria Vittoria Modica; Yehu Moran; Ayse Nalbantsoy; María Eugenia Pachón Ibáñez; Alexios Panagiotopoulos; Eitan Reuveny; Javier Sánchez Céspedes; Andy Sombke; Joachim M Surm; Eivind A B Undheim; Aida Verdes; Giulia Zancolli
Journal:  Gigascience       Date:  2022-05-18       Impact factor: 7.658

4.  Mechanism of C-type inactivation in the hERG potassium channel.

Authors:  Jing Li; Rong Shen; Bharat Reddy; Eduardo Perozo; Benoît Roux
Journal:  Sci Adv       Date:  2021-01-29       Impact factor: 14.136

Review 5.  Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels.

Authors:  Raminta Vaiciuleviciute; Daiva Bironaite; Ilona Uzieliene; Ali Mobasheri; Eiva Bernotiene
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

Review 6.  Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds.

Authors:  Rocio K Finol-Urdaneta; Aleksandra Belovanovic; Milica Micic-Vicovac; Gemma K Kinsella; Jeffrey R McArthur; Ahmed Al-Sabi
Journal:  Mar Drugs       Date:  2020-03-20       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.